Image

Continuous Monitoring of Vital Signs at Home (WARD HOME II)

Continuous Monitoring of Vital Signs at Home (WARD HOME II)

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The study aims to investigate the use of wireless, continuous monitoring in patients at home including the frequency of alarms triggered by abnormal vital parameters and their significance for (re)hospitalisation/Serious Adverse Events(SAE) and/or death within 30 days.

Description

Acute hospital admissions challenge the capacity of the healthcare system. Readmission is common among patients with chronic medical diseases, and many patients admitted for acute conditions are often subsequently observed at the hospital for hours and often with one overnight stay for observation purposes alone. Recent medico technical research has allowed continuous and wireless monitoring of patients' vital signs in-hospital, but the practice at home remains uninvestigated. However, the technology has the potential to relieve hospital overcrowding by offering continuous and real time analytics of vital signs in high-risk patients at home.

Eligibility

Inclusion Criteria:

        Adult patients (≥18 years) admitted (with at least one night stay) with an acute medical
        disease and scheduled for discharge to their own homes
        Adult patients (≥18 years) who have contacted the EMS and, after assessment by paramedic
        personnel, not deemed sick enough for immediate hospital admission.
        Exclusion Criteria:
        Patients placed on palliative treatment.
        Acceptable chronically abnormal vital parameters of SpO2<88%, MAP<70, RR>24, or HR>110.
        Allergy to plaster, plastic, or silicone.
        A pacemaker or Implantable Cardioverter Defibrillator (ICD) device.
        If the patient was deemed not able to open the front door when visited by the investigator.
        Inability to give informed consent.

Study details
    Vital Sign Monitoring
    Clinical Deterioration
    Hospital At Home

NCT06077851

Bispebjerg Hospital

26 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.